BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 25269580)

  • 1. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
    Mahn JJ; Dubey E; Brody A; Welch R; Zalenski R; Flack JM; Ference B; Levy PD
    Acad Emerg Med; 2014 Sep; 21(9):996-1002. PubMed ID: 25269580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E; Theofilis P; Mpahara A; Lazaros G; Niarchou P; Vogiatzi G; Tsalamandris S; Fountoulakis P; Christoforatou E; Mystakidou V; Anastasiou M; Goliopoulou A; Tousoulis D
    Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12728. PubMed ID: 31724804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients.
    Ishikawa J; Yamanaka Y; Toba A; Watanabe S; Harada K
    Int Heart J; 2017 Dec; 58(6):933-938. PubMed ID: 29162779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
    Okin PM; Wright JT; Nieminen MS; Jern S; Taylor AL; Phillips R; Papademetriou V; Clark LT; Ofili EO; Randall OS; Oikarinen L; Viitasalo M; Toivonen L; Julius S; Dahlöf B; Devereux RB
    Am J Hypertens; 2002 Aug; 15(8):663-71. PubMed ID: 12160187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    J Electrocardiol; 1996; 29 Suppl():256-61. PubMed ID: 9238409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
    Kohsaka S; Sciacca RR; Sugioka K; Sacco RL; Homma S; Di Tullio MR
    Am Heart J; 2005 Jan; 149(1):181-6. PubMed ID: 15660051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Electrocardiographic Criteria for Echocardiographically Diagnosed Left Ventricular Hypertrophy in Chinese Hypertensive Patients.
    Wang D; Xu JZ; Zhang W; Chen Y; Li J; An Y; Bian R; Wang JG
    Am J Hypertens; 2020 Sep; 33(9):831-836. PubMed ID: 32484222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of echocardiographic left ventricular hypertrophy with electrocardiography, body mass index and blood pressure.
    Varis JP; Puukka PJ; Karanko HM; Jula AM
    Blood Press; 2014 Feb; 23(1):39-46. PubMed ID: 23772751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
    Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
    J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
    Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
    Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study.
    Zhang W; Zhou Y; Bai B; Yu S; Xiong J; Chi C; Teliewubai J; Li J; Blacher J; Zhang Y; Xu Y
    Clin Interv Aging; 2019; 14():549-556. PubMed ID: 30880935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation.
    Okin PM; Gerdts E; Wachtell K; Oikarinen L; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2010 Jul; 28(7):1534-40. PubMed ID: 20589977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.